Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years - A Review of Published Literature.
Journal Information
Full Title: Clin Interv Aging
Abbreviation: Clin Interv Aging
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Disclosure Bilal Chughtai is a consultant for Olympus, Boston Scientific, Ferring Pharmaceuticals, and Allergan. Dean Elterman reports grants, personal fees from Boston Scientific, grants from Olympus, grants from Urotronic, grants from Procept Biorobotics, grants from Zenflow, outside the submitted work. Kevin C. Zorn is a consultant and proctor for Boston Scientific, Procept BioRobotics, and investigator for Zenflow. Naeem Bhojani is a consultant for Olympus, Boston Scientific, and Procept BioRobotics. Lori Lerner reports Uncompensated - Chair of the Clinical Events Committee (CEC) from Proverum, outside the submitted work. The authors declare that they have no other known competing interests."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025